Montes de Oca ME, Soler PLL, Noa PG, Barreto SE, Carmenates ABM, Reyes EAD

Language: Spanish
References: 29
Page: 150-161
PDF size: 234.35 Kb.

ABSTRACT

Background: biliopancreatic malignant tumors are not very frequent and have bad prognosis. Endoscopic retrograde cholangiopancreatography constitutes the most important diagnostic and therapeutic option for advanced stages.
Objective: to describe the diagnosis and therapeutics of biliopancreatic malignant tumors by means of endoscopic retrograde cholangiopancreatography at Manuel Ascunce Domenech University Hospital, from January 2005 to July 2010.
Methods: a cross-sectional descriptive study was conducted. The universe was composed of 600 patients who underwent endoscopic retrograde cholangiopancreatography. The sample was made up of 75 cases with diagnosis of malignant tumor of bile ducts or pancreas, was selected through a non-probabilistic sample. The information of the endoscopic retrograde cholangiopancreatography registrations was collected in a form and was processed by means of SPSS statistical system.
Results: the age group of 70-79 years (34.6 %) and the male sex (62.7 %) predominated. The 90.6 % of patients presented jaundice. Computed axial tomography provided positive data in 72.4 % of cases, while ultrasound did it in 67.6 %. The 45.3 % of the diagnoses obtained through endoscopic retrograde cholangiopancreatography were pancreatic tumors. Sphincterectomy and the placing of endoprosthesis were performed in the 17.3 % and 16 % of the cases, respectively. Pancreatitis prevailed as a complication (2.6%).
Conclusions: biliopancreatic malignant tumors are more frequent in patients older than 70 years and in men. Neoplasias of the head of pancreas are the most frequent within this group and the endoscopic retrograde cholangiopancreatography constitutes the main study for the diagnosis and palliative treatment of these affections, with few complications associated.

REFERENCES

1. Blechacz B, Gores GJ. Tumors of the Bile Ducts, Gallbladder and Ampulla. In: Feldman M, Friedman LS, Sleisenger MI, editors. Gastrointestinal and Liver Disease. 8.ª ed. New York: Elsevier Inc; 2010. p. 1171-83.

2. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28(4-5):645-56.

3. Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011 Nov;34(9):1063-78.

4. Stockland AH, Baron TH. Endoscopic and Radiologic treatment of biliary diseases. In: Feldman M, Friedman LS, Sleisenger MI, editors. Gastrointestinal and liver diseases. 8th ed. New York: Elsevier Inc; 2010. p. 1185-93.

5. Distler M, Kersting S, Rückert F, Dobrowolski F, Miehlke S, Grützmann R, et al. Palliative treatment of obstructive jaundice in patients with carcinoma of the pancreatic head or distal biliary tree. Endoscopic stent placement vs. hepaticojejunostomy. JOP. 2010 Nov 9;11(6):568-74.

6. Morán Tisoc L, Cumpa Quiroz R, Vargas Cárdenas G, Astete Benavides M, Valdivia Roldan M. Characteristics of the endoscopic retrograde cholangiopancreatography in a national referral center. Rev Gastroenterol Peru. 2005 Apr-Jun;25(2):161-7.

7. Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA, et al. ASGE Guideline: The role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62(1):1-8.

8. Godoy Briceño A, Herrera Mejias J, Luizzi Torre J, Machado Ochoa T, Salas Marcano I, Delgado Ortega G. Experiencia en el tratamiento quirúrgico de las neoplasias periampulares. Rev Venez Cir. 2006;59(1):18-22.

9. Soriano García JL, Galán Álvarez Y, Luaces Álvarez P, Martín García A, Arrebola Suárez JA, Carrillo Franco G. Incidencia en cuba del cáncer en la tercera edad. Rev Cubana Oncol. 1998;14(2):121-8.

10. Savío López AM, Copo Jorge JA, Martínez Blanco CA, Soliva Domínguez R. Pancreatoduodenectomía Cefálica en los tumores periampulares: experiencia en nuestro centro y revisión del tema. Rev Cubana Cir. 2001;40(4):284-90.

11. Brizuela Quintanilla R, Fábregas Rodríguez C. Experiencia en el tratamiento endoscópico de la obstrucción de la vía biliar principal. Rev Cub Med Mil. 2003;32(2):81-7.

12. Moghimi M, Marashi SA, Salehian MT, Sheikhvatan M. Obstructive jaundice in Iran: factors affecting early outcome. Hepatobiliary Pancreat Dis Int. 2008;7(5):515-9.

13. Ginès Gibert A, Maurel Santasusana J. Tumores biliopancreáticos. In: Ponce García J, editor. Manual de Tratamiento de las Enfermedades Gastroenterológicas. 3ra ed. Madrid: Elsevier Doyma; 2011p.455-65.

14. Cuevas Ibañez A, Boned Purkiss J, Martin Rodríguez J, Fernandez Iglesias P, Cano Herrera M, Esteban Alonso A. Aportación de la ecografía y de la tomografía computarizada en el estudio del páncreas. Gastroenterología Integrada. 2000;1(6):413-20.

15. Sahani DV, Shah ZK, Catalano OA, Boland GW, Brugge WR. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol. 2008 Jan;23(1):23-33.

16. Zhong L, Yao QY, Li L, Xu JR. Imaging diagnosis of pancreato-biliary diseases: a control study. World J Gastroenterol. 2003 Dec;9(12):2824-7.

17. Nuernberg D, Ignee A, Dietrich CF. Aktueller Stand der Sonographie in der Gastroenterologie. Biliopankreatisches System. Med Klin (Munich). 2007 Feb 15;102(2):112-26.

18. Brizuela Quintanilla R, Ruiz Torres J, Fábregas Rodríguez C, Martínez López R, Pernia González L, Díaz-Canel Fernández O. Aplicaciones diganósticas y terapeúticas de la Colangiopancreatografía retrograda endoscópica. Rev Cubana Med Milit. 2003;29(3):162-7.

19. Goh KL, Murugan P, Anbarasu R, Tan YM, Ranjeev P. Endoscopic Management of Pancreatico-biliary,Strictures: A malaysian experience. Digestive Endoscopy. 2005;17(Suppl.):S80–4.

20. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB. 2008;10:77-82.

21. Patel T, Singh P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol. 2007;23:317-23.

22. Nguyen K, Sing JT. Review of endoscopic techniques in the diagnosis and management of cholangiocarcinoma. World J Gastroenterol. 2008;14(19):2995-9.

23. García-Cano Lizcano J, González Martín JA, Morillas Ariño MJ, Pérez García JI, Redondo Cerezo E, Jimeno Ayllón C, et al. Resultados del drenaje de la vía biliar por CPRE en pacientes con edad geriátrica. Rev esp enferm dig. 2007 Aug;99(8):451-56.

24. Ruiz Torres J, Brizuela Quintanilla RA, Martínez López R, Díaz-Canel Fernández O, Pernía González L. Colangiografía Retrógrada Endoscópica, experiencia de 14 años de un centro de concentración, de alta especialidad. Rev Med Mex. 2009;21(4):27.

25. Park SY, Park CH, Cho SB, Yoon KW, Lee WS, Kim HS, et al. The safety and effectiveness of endoscopic biliary decompression by plastic stent placement in acute suppurative cholangitis compared with nasobiliary drainage. Gastrointest Endosc. 2008 Dec;68(6):1076-80.

26. Cotton P, Garrow D, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80-8.

27. Wang P, Li ZS, Liu F, Ren X, Lu NH, Fan ZN, et al. Risk Factors for ERCP-Related Complications: A Prospective Multicenter Study. Am J Gastroenterol. 2009;104(1):31-40.

28. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56:652-6.

29. Yriberry Ureña S, Salazar Muente F, Monge Zapata V, Prochazka Zárate R, Vila Gutiérrez S, Barriga Briceño JA, et al. Eventos Adversos Esperados e Inesperados en la Endoscopía Terapéutica de la Vía Biliar (CPRE): Experiencia en un Centro Privado Nacional con 1356 casos consecutivos (1999-2008). Rev Gastroenterol Perú. 2009;29(4):311-20.